Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 5. Rapid correction of low vitamin D status in nursing home residents
Your Article Summary
See Latest ArticlesInfluence of Trough Serum Levels and Immunogenicity on Long-term Outcome of Adalimumab Therapy in Crohn's Disease
Gastroenterology, 10/28/09
Karmiris K et al. – Introduction of adalimumab after failure of infliximab therapy resulted in a sustained clinical benefit in two thirds of patients during a median follow–up period of almost 2 years. Discontinuation was directly related to low adalimumab trough serum concentration, which was observed more frequently in patients who developed antibodies against adalimumab.
Related Articles
A Case-Control Study on Risk Factors of Osteoporosis in Patients with Crohn's Disease
Archives of Iranian Medicine, 11/13/09
Relevance Score: 69%
Gastrointestinal stromal tumor causing small bowel intussusception in a patient with Crohn's disease
World Journal of Gastroenterology, 11/13/09
Relevance Score: 69%
Campylobacter concisus and other Campylobacter species in children with newly diagnosed Crohns disease
Inflammatory Bowel Disease, 11/05/09
Relevance Score: 69%
C-Reactive Protein and Disease Activity in Children with Crohns Disease
Digestive Diseases and Sciences, 10/26/09
Relevance Score: 69%
Malignant Transformation in Perianal Fistulas of Crohns Disease: a Systematic Review of Literature
Journal of Gastrointestinal Surgery, 10/21/09
Relevance Score: 69%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Omeprazole induces gastric transmucosal permeability to the peptide bradykinin
World Journal of Gastroenterology, 03/10/10
Type 2 diabetes: postprandial hyperglycemia and increased cardiovascular risk
Vascular Health and Risk Management, 03/10/10
A comparison of methadone, buprenorphine and alpha2 adrenergic agonists for opioid detoxification: A mixed treatment comparison meta-analysis
Drug and Alcohol Dependence, 03/10/10
Article Search
Sponsor
Sponsor